It has also been shown that human IL-13-producing ILC2s can acquire the capacity to produce IFN-γ in response to IL-12, and ILC2s co-expressing IL-13 and IFN-γ are detectable in the inflamed gut of CD patients (108). This evidence concerns the gene IFNG and Cowden disease.